Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11206594 | 0.86 | LMNA (0.50) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Mannitol SCHEMBL29235000 | 0.84 | LMNA (0.61) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Mannitol SCHEMBL1504919 | 0.84 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Mannitol SCHEMBL28204430 | 0.84 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Mannitol SCHEMBL28023612 | 0.81 | USP2 (0.65) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL4724595 | 0.80 | PDE4A (0.62) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL30891962 | 0.80 | PDE4A (0.62) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL20576207 | 0.80 | PDE4A (0.62) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL1569332 | 0.80 | PDE4A (0.62) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL31465077 | 0.80 | PDE4A (0.62) | LMNAL3MBTL1TDP1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100173793-A1 | PEPTIDE / PROTEIN IDENTIFICATION USING PHOTOREACTIVE CARRIERS FOR THE IMMOBILISATION OF THE LIGANDS | UNIVERSITY OF WARWICK (GB) | 2010-07-08 | — | — | US | disclosed |
| EP-1926992-A2 | PEPTIDE / PROTEIN IDENTIFICATION USING PHOTOREACTIVE CARRIERS FOR THE IMMOBILISATION OF THE LIGANDS | THE UNIVERSITY OF WARWICK (GB) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007020453-A2 | PEPTIDE / PROTEIN IDENTIFICATION USING PHOTOREACTIVE CARRIERS FOR THE IMMOBILISATION OF THE LIGANDS | UNIVERSITY OF WARWICK (GB) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173793-A1 | PEPTIDE / PROTEIN IDENTIFICATION USING PHOTOREACTIVE CARRIERS FOR THE IMMOBILISATION OF THE LIGANDS | CLTA, CD40, DNPEP | LMNA 4613/4885L3MBTL1 2165/4885TDP1 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.